date,title,source
Nov-09-18,NASH clinical trial presentation and continued revenue growth,GlobeNewswire
Nov-19-18,"Immuron Appoints Gary S. Jacob, Ph.D., Experienced US Based Biotechnology Executive, as CEO",GlobeNewswire
Nov-26-18,One Thing To Remember About The Immuron Limited (ASX:IMC) Share Price,Simply Wall St.
Jan-08-19,Immuron Receives $1.19M R&D Tax Concession Refund,GlobeNewswire
Feb-11-19,What You Must Know About Immuron Limiteds (ASX:IMC) Financial Strength,Simply Wall St.
Apr-11-19,Immuron Receives U.S. Patent on Drug Composition to Treat Clostridium difficile,GlobeNewswire
Apr-11-19,Immuron Aims to Secure FDA Approval for IMM-124E to Prevent Travelers Diarrhea,GlobeNewswire
Apr-15-19,Do Institutions Own Immuron Limited (ASX:IMC) Shares?,Simply Wall St.
Apr-15-19,Immuron sales surge by 66% in the Third Quarter of FY19,GlobeNewswire
Apr-17-19,Immuron Appoints CEO Dr. Gary S. Jacob to Board of Directors,GlobeNewswire
Apr-30-19,"Immuron CEO Dr. Gary S. Jacob to Present at the ThinkEquity Conference on May 2, 2019",GlobeNewswire
May-23-19,Immuron Prices Underwritten Public Offering of ADSs,GlobeNewswire
May-23-19,Immuron Announces Proposed Public Offering of ADSs,GlobeNewswire
May-30-19,Immuron Announces the Closing of Public Offering of ADSs,GlobeNewswire
Jun-07-19,How Much Are Immuron Limited (ASX:IMC) Insiders Spending On Buying Shares?,Simply Wall St.
Jun-12-19,Immuron Rips Higher On Positive Preclinical Results For Travelan,Benzinga
